Skip to main content



Probiotics was a term first used by Lilly and Stillwell in 1965 to describe microorganisms that confer beneficial properties on other microorganism. Since then, the term has evolved to incorporate any organism that has beneficial impact on another organism. Research into probiotics and their health implications has been extensive. This collection highlights the latest research into probiotics published in Gut Pathogens. If you would like your manuscript to be considered for this collection, please indicate so at the time of submission.

  1. Research

    Gleaning evolutionary insights from the genome sequence of a probiotic yeast Saccharomyces boulardii

    The yeast Saccharomyces boulardii is used worldwide as a probiotic to alleviate the effects of several gastrointestinal diseases and control antibiotics-associated diarrhea. While many studies report the probioti...

    Indu Khatri, Akil Akhtar, Kamaldeep Kaur, Rajul Tomar, Gandham Satyanarayana Prasad, Thirumalai Nallan Chakravarthy Ramya and Srikrishna Subramanian

    Gut Pathogens 2013 5:30

    Published on: 22 October 2013

  2. Review

    Timely approaches to identify probiotic species of the genus Lactobacillus

    Over the past decades the use of probiotics in food has increased largely due to the manufacturer’s interest in placing “healthy” food on the market based on the consumer’s ambitions to live healthy. Due to th...

    Stefan R Herbel, Wilfried Vahjen, Lothar H Wieler and Sebastian Guenther

    Gut Pathogens 2013 5:27

    Published on: 24 September 2013

  3. Review

    Emerging importance of holobionts in evolution and in probiotics

    The existence of microbe free animals or plants in nature is virtually impossible as they and plants have a certain degree of symbiotic association with microbes. This symbiotic association leads to the format...

    Yadvir Singh, Javed Ahmad, Javed Musarrat, Nasreen Z Ehtesham and Seyed E Hasnain

    Gut Pathogens 2013 5:12

    Published on: 22 May 2013

  4. Research

    In vitro evaluation of anti-infective activity of a Lactobacillus plantarum strain against Salmonella enterica serovar Enteritidis

    Salmonella enterica serovar Enteritidis infections are known to exhibit worldwide prevalence with increased morbidity and mortality. The conventional strategies like antibiotic therapy and vaccination have not on...

    Jugal Kishore Das, Debasmita Mishra, Pratikshya Ray, Prangya Tripathy, Tushar K Beuria, Neera Singh and Mrutyunjay Suar

    Gut Pathogens 2013 5:11

    Published on: 13 May 2013

  5. Meeting report

    Probiotics for human health –new innovations and emerging trends

    The role of the gut microbiome in human health and disease with a particular emphasis on therapeutic use of probiotics under specific medical conditions was mainly highlighted in 1st Annual conference of Probi...

    Sunita Grover, Hogarehalli Mallapa Rashmi, Anil Kumar Srivastava and Virender Kumar Batish

    Gut Pathogens 2012 4:15

    Published on: 26 November 2012

  6. Research

    Bacillus coagulans GBI-30, 6086 limits the recurrence of Clostridium difficile-Induced colitis following vancomycin withdrawal in mice

    Recently, we found that the probiotic strain Bacillus coagulans GBI-30, 6086 (GanedenBC30) improved indices of Clostridium difficile (C. difficile)-induced colitis in mice (Fitzpatrick et al., Gut Pathogens, 2011...

    Leo R Fitzpatrick, Jeffrey S Small, Wallace H Greene, Kelly D Karpa, Sean Farmer and David Keller

    Gut Pathogens 2012 4:13

    Published on: 22 October 2012

  7. Research

    Quorum sensing in the probiotic bacterium Escherichia coli Nissle 1917 (Mutaflor) – evidence that furanosyl borate diester (AI-2) is influencing the cytokine expression in the DSS colitis mouse model

    “Quorum sensing” (QS) is the phenomenon which allows single bacterial cells to measure the concentration of bacterial signal molecules. Two principle different QS systems are known, the Autoinducer 1 system (A...

    Christoph A Jacobi, Stefanie Grundler, Chih-Jen Hsieh, Julia Stefanie Frick, Patrick Adam, Georg Lamprecht, Ingo B Autenrieth, Michael Gregor and Peter Malfertheiner

    Gut Pathogens 2012 4:8

    Published on: 3 August 2012

  8. Meeting report

    Health impact of probiotics - vision and opportunities

    Our understanding of the role of the microbiota in our gut and other sites in our body is rapidly emerging and could lead to many new and innovative approaches for health care. The promise of the potential rol...

    Neerja Hajela, G Balakrish Nair, Philip Abraham and Nirmal K Ganguly

    Gut Pathogens 2012 4:1

    Published on: 12 March 2012

  9. Hypothesis

    Epigenome targeting by probiotic metabolites

    The intestinal microbiota plays an important role in immune development and homeostasis. A disturbed microbiota during early infancy is associated with an increased risk of developing inflammatory and allergic...

    Paul V Licciardi, Sook-San Wong, Mimi LK Tang and Tom C Karagiannis

    Gut Pathogens 2010 2:24

    Published on: 21 December 2010

  10. Commentary

    Probiotic therapy - recruiting old friends to fight new foes

    Against a backdrop of increasing antibiotic resistance, and the emergence of new and evolving pathogens, clinicians are increasingly forced to consider alternative therapies - probiotics are one such alternative.

    Roy D Sleator

    Gut Pathogens 2010 2:5

    Published on: 25 June 2010

  11. Short report

    A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome

    Chronic fatigue syndrome (CFS) is complex illness of unknown etiology. Among the broad range of symptoms, many patients report disturbances in the emotional realm, the most frequent of which is anxiety. Resear...

    A Venket Rao, Alison C Bested, Tracey M Beaulne, Martin A Katzman, Christina Iorio, John M Berardi and Alan C Logan

    Gut Pathogens 2009 1:6

    Published on: 19 March 2009